Specific financial terms of the deal weren’t disclosed, but South San Francisco-based Genentech will make an upfront payment and be responsible for all development work. Genentech will have the option to buy the entire program from Forma.
Monday, June 27, 2011
Genentech buys into Forma cancer drug program
Specific financial terms of the deal weren’t disclosed, but South San Francisco-based Genentech will make an upfront payment and be responsible for all development work. Genentech will have the option to buy the entire program from Forma.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment